EPMN, Anosys licensing deal

Epimmune (EPMN) granted Anosys (Menlo Park, Calif.), a worldwide non-exclusive license, outside Japan, to certain breast, colon, lung and prostate antigens for ex vivo cancer therapies. The agreement ...